1.Research progress of Antrodia cinnomomea on the anti-hepatocarcinoma mechanism
Qingfa CHEN ; Zongjie ZHAO ; Haitao XIE ; Xiangyang ZHANG ; Pengting WANG
Journal of International Oncology 2015;(6):469-471
Extensive in vitro studies reveal that multiple intracellular targets of Antrodia cinnomomea affect cell growth,apoptosis,angiogenesis,invasion and metastasis.These intracellular targets include tumor suppressor gene,cell cycle regulatory protein,transcription factor,angiogenic and metastatic factors,and apop-totic and survival regulators.In addition,Antrodia cinnomomea has immunomodulatory propertie,which plays an anti-cancer effect indirectly by means of enhancing immunity.
2.Anti-inflammatory effect of triterpenoids from Antrodia camphorat a
Yihong ZHANG ; Zongjie ZHAO ; Haitao XIE ; Xiangyang ZHANG ; Yu SONG
Chinese Journal of Pathophysiology 2015;(2):369-373
The morbidity of inflammation-associated tumor is high .Prevention and treatment of inflammation play a positive role in delaying the occurrence and development of cancer .Antrodia camphorata, an endemic fungus in Tai-wan, possesses significant anti-inflammatory effect.So far, 35 anti-inflammatory active components from Antrodia camphorata have been identified , among which triterpenoids account for the most .Studies have revealed that triterpenoids , including ergostanes and lanostanes , have significant anti-inflammatory activities .Because of their structures , especially those of the ergostanes , are similar to the structures of cholesterol and steroid hormones , their anti-inflammatory mechanism may be related to mimic the steroid hormones or interfere with the effect of cholesterol .
3. Advances in evidence-based medical research of GnRHa for fertility protection after chemotherapy
Quanfeng ZHAO ; Peishu FU ; Wenrui GU ; Dan ZHEN ; Zongjie LV ; Yang YANG
Chinese Journal of Clinical Pharmacology and Therapeutics 2021;26(12):1449-1454
With an improvement in the long-term survival rates of cancer patients, the requirements for fertility protection of young cancer patients after chemotherapy are increasingly prominent. Early studies have shown that gonadotropin-releasing hormone agonist (GnRHa) has a protective effect on fertility. But in recenct year, relevant studies have shown that its protective effect is controversial. This article reviews the clinical researches of GnRHa for fertility protection in patients with common tumors, and explores its evidence-based medicine, in the hope of providing references for reasonable clinical application.